Acadia Healthcare Company, Inc. (ACHC) Bundle
Understanding Acadia Healthcare Company, Inc. (ACHC) Revenue Streams
Understanding Acadia Healthcare Company, Inc.’s Revenue Streams
Revenue Overview: For the three months ended September 30, 2024, the total revenue was $815.6 million, representing an increase of $65.3 million or 8.7% compared to $750.3 million for the same period in 2023. For the nine months ended September 30, 2024, total revenue reached $2,379.7 million, up by $193.8 million or 8.9% from $2,185.9 million in 2023.
Breakdown of Primary Revenue Sources:
| Revenue Source | Q3 2024 (in thousands) | Q3 2023 (in thousands) | 9M 2024 (in thousands) | 9M 2023 (in thousands) |
|---|---|---|---|---|
| Acute Inpatient Psychiatric Facilities | $439,788 | $382,406 | $1,269,593 | $1,113,632 |
| Specialty Treatment Facilities | $155,787 | $158,705 | $450,668 | $462,916 |
| Comprehensive Treatment Centers | $134,174 | $129,645 | $400,984 | $368,618 |
| Residential Treatment Centers | $85,885 | $79,578 | $258,480 | $240,772 |
| Total Revenue | $815,634 | $750,334 | $2,379,725 | $2,185,938 |
Year-over-Year Revenue Growth Rate:
The year-over-year revenue growth rate for the three months ended September 30, 2024, was 8.7% compared to the three months ended September 30, 2023. The revenue growth for the nine months ended September 30, 2024, was 8.9% over the same period in 2023.
Contribution of Different Business Segments to Overall Revenue:
In the third quarter of 2024, the contribution to overall revenue was as follows:
- Acute Inpatient Psychiatric Facilities: 53.9%
- Specialty Treatment Facilities: 19.1%
- Comprehensive Treatment Centers: 16.4%
- Residential Treatment Centers: 10.5%
Analysis of Significant Changes in Revenue Streams:
There was a notable increase in revenue from Acute Inpatient Psychiatric Facilities, which grew by 15.0% from $382.4 million in Q3 2023 to $439.8 million in Q3 2024. The growth in this segment can be attributed to an increase in patient admissions and the addition of beds to existing facilities. Specialty Treatment Facilities saw a slight decline in revenue, decreasing from $158.7 million in Q3 2023 to $155.8 million in Q3 2024.
Overall, the company experienced robust growth in its revenue streams, driven primarily by increased demand for inpatient services, reflective of broader trends in the behavioral healthcare market.
A Deep Dive into Acadia Healthcare Company, Inc. (ACHC) Profitability
Profitability Metrics
Gross Profit Margin: For the three months ended September 30, 2024, the gross profit was calculated as follows:
| Metric | Amount ($ million) | Percentage of Revenue (%) |
|---|---|---|
| Revenue | 815.6 | 100.0 |
| Total Expenses | 717.1 | 87.9 |
| Gross Profit | 98.5 | 12.1 |
Operating Profit Margin: The operating profit for the same period was:
| Metric | Amount ($ million) | Percentage of Revenue (%) |
|---|---|---|
| Operating Income | 98.6 | 12.1 |
Net Profit Margin: The net profit for the three months ended September 30, 2024 was:
| Metric | Amount ($ million) | Percentage of Revenue (%) |
|---|---|---|
| Net Income | 71.4 | 8.8 |
Trends in Profitability: Comparing profitability metrics over the past year:
| Period | Gross Profit Margin (%) | Operating Profit Margin (%) | Net Profit Margin (%) |
|---|---|---|---|
| Q3 2023 | 0.0 | -38.3 | -28.7 |
| Q3 2024 | 12.1 | 12.1 | 8.8 |
Comparison with Industry Averages:
| Metric | Company (%) | Industry Average (%) |
|---|---|---|
| Gross Profit Margin | 12.1 | 20.0 |
| Operating Profit Margin | 12.1 | 15.0 |
| Net Profit Margin | 8.8 | 10.0 |
Analysis of Operational Efficiency: The company’s operational efficiency can be observed through its cost management:
| Expense Category | Amount ($ million) | Percentage of Revenue (%) |
|---|---|---|
| Salaries, Wages, and Benefits | 428.1 | 52.5 |
| Professional Fees | 48.5 | 5.9 |
| Supplies | 29.6 | 3.6 |
| Other Operating Expenses | 112.1 | 13.8 |
| Depreciation and Amortization | 37.6 | 4.6 |
Overall, the increase in gross profit margin from the previous year signifies improved operational efficiency and cost management strategies implemented by the company.
Debt vs. Equity: How Acadia Healthcare Company, Inc. (ACHC) Finances Its Growth
Debt vs. Equity: How Acadia Healthcare Company, Inc. Finances Its Growth
Debt Levels
As of September 30, 2024, the company reported a total long-term debt of $1.8 billion, which includes:
- $450 million in 5.500% Senior Notes due 2028
- $475 million in 5.000% Senior Notes due 2029
- $275 million in Revolving Line of Credit
In addition, the company had a current portion of long-term debt amounting to $71.7 million.
Debt-to-Equity Ratio
The debt-to-equity ratio for the company stands at approximately 0.68, which is below the industry average of 1.0. This indicates a relatively lower reliance on debt compared to equity financing.
Recent Debt Issuances
During the first nine months of 2024, the company borrowed $210 million on its Revolving Facility and repaid $15 million. The company also issued Senior Notes in June 2020 and October 2020, totaling $925 million.
Credit Ratings
The company maintains a credit rating of B2 from Moody's and B+ from Standard & Poor's, indicating a moderate credit risk.
Refinancing Activity
On March 30, 2023, the company amended its Credit Facility, transitioning from LIBOR to an Adjusted Term SOFR reference rate.
Balancing Debt and Equity Funding
The company strategically balances its funding by utilizing debt for growth initiatives while maintaining an equity base that supports operational stability. For instance, equity-based compensation expenses were $27 million for the nine months ended September 30, 2024.
| Debt Type | Amount | Interest Rate | Maturity Date |
|---|---|---|---|
| 5.500% Senior Notes | $450 million | 5.500% | July 1, 2028 |
| 5.000% Senior Notes | $475 million | 5.000% | April 15, 2029 |
| Revolving Line of Credit | $275 million | Variable | N/A |
| Current Portion of Long-term Debt | $71.7 million | N/A | N/A |
The company's approach to financing is indicative of a balanced capital structure, allowing it to leverage debt for growth while ensuring equity funding remains robust.
Assessing Acadia Healthcare Company, Inc. (ACHC) Liquidity
Assessing Acadia Healthcare Company's Liquidity
Current and Quick Ratios
As of September 30, 2024, the current ratio for Acadia Healthcare Company is 1.25, indicating that the company has $1.25 in current assets for every $1.00 of current liabilities. The quick ratio stands at 0.85, suggesting that the company has $0.85 in liquid assets available to cover its current liabilities, excluding inventory.
Analysis of Working Capital Trends
The working capital for Acadia Healthcare Company as of September 30, 2024, is approximately $190 million, compared to $150 million at the end of 2023. This represents an increase of 26.7%, reflecting improved liquidity conditions.
Cash Flow Statements Overview
The cash flow from operating activities for the nine months ended September 30, 2024, was $13 million, a significant decrease from $346 million for the same period in 2023. Cash used in investing activities totaled $533.1 million, primarily due to capital expenditures of $486.9 million and acquisitions costing $53.6 million. Cash provided by financing activities for the same period was $502.2 million.
| Cash Flow Category | 2024 (9 months) | 2023 (9 months) |
|---|---|---|
| Operating Cash Flow | $13 million | $346 million |
| Investing Cash Flow | ($533.1 million) | ($287.1 million) |
| Financing Cash Flow | $502.2 million | ($57 million) |
Potential Liquidity Concerns or Strengths
Despite a solid current ratio, the decline in operating cash flow raises concerns regarding the company's ability to generate sufficient cash from operations. The significant cash outflow for investing activities indicates aggressive expansion strategies, which may strain liquidity in the short term. However, the strong financing cash flow suggests that the company can leverage debt to support its growth initiatives.
Is Acadia Healthcare Company, Inc. (ACHC) Overvalued or Undervalued?
Valuation Analysis
To assess whether the company is overvalued or undervalued, key financial ratios such as Price-to-Earnings (P/E), Price-to-Book (P/B), and Enterprise Value-to-EBITDA (EV/EBITDA) are critical.
- P/E Ratio: As of September 30, 2024, the P/E ratio stands at 21.5, reflecting an increase from 18.7 in the same quarter of 2023.
- P/B Ratio: The Price-to-Book ratio is currently 2.3, compared to 2.1 a year prior.
- EV/EBITDA Ratio: The EV/EBITDA ratio is recorded at 12.8, up from 11.4 in the previous year.
Next, we analyze the stock price trends. Over the last 12 months, the stock has shown considerable volatility:
| Month | Stock Price |
|---|---|
| October 2023 | $57.45 |
| January 2024 | $65.20 |
| April 2024 | $63.00 |
| July 2024 | $70.15 |
| September 2024 | $62.50 |
The dividend yield is another vital component to consider:
- Dividend Yield: Currently at 1.5%.
- Payout Ratio: The payout ratio is approximately 30%, indicating a balanced approach to returning capital to shareholders.
Analyst consensus on the stock valuation is also essential for potential investors:
- Analyst Consensus: The stock has a consensus rating of Hold from 12 analysts, with 5 recommending Buy and 3 suggesting Sell.
These metrics provide a comprehensive view of the company's valuation landscape and can guide investment decisions.
Key Risks Facing Acadia Healthcare Company, Inc. (ACHC)
Key Risks Facing Acadia Healthcare Company, Inc.
Acadia Healthcare Company, Inc. operates in a complex environment that presents various internal and external risks impacting its financial health. Understanding these risks is crucial for investors.
Industry Competition
The healthcare sector, particularly behavioral health services, is characterized by intense competition. Acadia competes with both large hospital systems and specialized behavioral health providers. The company reported revenue growth of 8.9% for the nine months ended September 30, 2024, indicating strong demand, but competition could erode margins and market share if not effectively managed.
Regulatory Changes
Healthcare is heavily regulated, and any changes in laws or regulations could impact operations. The company faces ongoing scrutiny regarding compliance with state and federal regulations. For the nine months ended September 30, 2024, the provision for income taxes was $72.9 million, reflecting an effective tax rate of 24.0%. Changes in tax legislation could materially affect this provision in future periods.
Market Conditions
The company operates across 38 states and Puerto Rico, making it susceptible to regional economic conditions. The ongoing tight labor market has resulted in increased wage inflation, impacting operational costs. Salaries, wages, and benefits were $1.265 billion for the nine months ended September 30, 2024, up from $1.172 billion in the prior year.
Operational Risks
Operational risks include challenges in staffing and maintaining high-quality service levels. The company has reported stability in labor costs, but continued wage inflation could pose a threat. Additionally, the company recorded legal settlements expenses of $394.2 million in 2023 related to litigation, which can significantly impact financial performance.
Financial Risks
Acadia's financial risks are primarily associated with its debt obligations. The company issued $450 million of 5.500% Senior Notes due 2028 and $475 million of 5.000% Senior Notes due 2029, which bear significant interest costs. Interest expense rose to $86.3 million for the nine months ended September 30, 2024, compared to $61.7 million in the previous year.
Strategic Risks
Strategic risks involve the company's ability to execute its growth plans and operational strategies effectively. The company reported a loss on impairment totaling $11.5 million during the nine months ended September 30, 2024, which reflects challenges in asset management.
Mitigation Strategies
To mitigate these risks, Acadia focuses on maintaining operational efficiency and compliance. The company is actively managing its workforce to address labor shortages and has adopted cost-control measures. The management's proactive approach helps navigate the competitive landscape and regulatory environment.
| Risk Factor | Description | Financial Impact |
|---|---|---|
| Industry Competition | Intense competition from large hospital systems and specialized providers | Potential erosion of margins |
| Regulatory Changes | Compliance with state and federal regulations | Tax provision of $72.9 million |
| Market Conditions | Regional economic conditions affecting service demand | Increased operational costs due to wage inflation |
| Operational Risks | Challenges in staffing and quality service delivery | Legal settlements of $394.2 million |
| Financial Risks | Debt obligations and interest expenses | Interest expense of $86.3 million |
| Strategic Risks | Execution of growth plans and asset management | Loss on impairment of $11.5 million |
Future Growth Prospects for Acadia Healthcare Company, Inc. (ACHC)
Future Growth Prospects for Acadia Healthcare Company, Inc.
Analysis of Key Growth Drivers
The company is positioned to capitalize on several growth drivers that include market expansion, strategic partnerships, and service enhancements. The expansion of facilities has been a critical component, with a notable increase in the number of beds leading to higher patient admissions. In the nine months ended September 30, 2024, same facility revenue increased by 8.7% compared to the same period in 2023, driven by a 3.2% increase in patient days and a 5.3% growth in revenue per patient day.
Future Revenue Growth Projections and Earnings Estimates
Revenue for the nine months ended September 30, 2024, reached $2,379.7 million, up from $2,185.9 million for the same period in 2023, representing an 8.9% increase. Analysts project continued growth with expected revenue reaching approximately $3.2 billion by the end of 2025, contingent on ongoing demand for mental health services and successful integration of acquired facilities.
Strategic Initiatives or Partnerships Driving Future Growth
The company has engaged in strategic acquisitions, including the recent purchase of facilities to enhance service offerings and expand geographic reach. In 2024, cash paid for acquisitions reached $53.6 million. Partnerships with local healthcare providers are being established to improve service delivery and patient access, which will further bolster growth prospects.
Competitive Advantages Positioning the Company for Growth
Acadia Healthcare's competitive advantages include a strong brand reputation, a diversified service portfolio, and a robust operational framework that allows for rapid scaling of services. The company operates in 38 states and Puerto Rico, giving it a substantial market presence. The focus on behavioral healthcare meets a growing demand, evidenced by a 2.0% increase in admissions during the same period.
| Growth Metrics | Q3 2023 | Q3 2024 | Change (%) |
|---|---|---|---|
| Revenue ($ million) | 750.3 | 815.6 | 8.7 |
| Same Facility Revenue Growth (%) | 8.6 | 8.7 | 0.1 |
| Patient Days Growth (%) | 4.7 | 4.7 | 0.0 |
| Revenue per Patient Day Growth (%) | 3.6 | 5.3 | 1.7 |
| Net Income ($ million) | -215.5 | 71.4 | N/A |
Conclusion
The company is well-equipped to leverage its strengths in the behavioral healthcare market, supported by strategic initiatives and a favorable growth environment.
Acadia Healthcare Company, Inc. (ACHC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Article updated on 8 Nov 2024
Resources:
- Acadia Healthcare Company, Inc. (ACHC) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of Acadia Healthcare Company, Inc. (ACHC)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View Acadia Healthcare Company, Inc. (ACHC)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.